Senior insider sale
See "Remarks" at TEVA PHARMACEUTICAL INDUSTRIES LTD — senior position signals high conviction
$6.23M
216.89K shares
What this filing means
SABAG MARK plans to sell 216.89K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD valued at approximately $6.23M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/9/2025ACC: 0001973379-25-000316
Officer· See "Remarks"
Since Mar 2026
216.89K
Shares to sell
$6.23M
Approx. market value
216.89K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
CASHLESS EXERCISE STOCK OPTIONS
CASH
12/9/2025
118.72KSHARES FROM ROLLOVER
COMPENSATION
3/1/2021
98.17KTotal acquired216.89K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/9/2025 | CASHLESS EXERCISE STOCK OPTIONS CASH | 118.72K | — |
3/1/2021 | SHARES FROM ROLLOVER COMPENSATION | 98.17K | — |
| Total | 216.89K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
216.89K
Market value
$6.23M
12/9/2025
Total
Units
216.89K
Value
$6.23M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/9/2025 | 216.89K | $6.23M | NYSE | Planned |
| Total | 216.89K | $6.23M | ||